A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)

Name: A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)
Published: 2022
License: Public Domain

Xenikos · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

steroid-refractory acute graft versus host disease, t-guard, ruxolitinib, steroid-refractory, gvhd, acute gvhd, agvhd, grade iii, grade iv, complete response (cr), transplant, hematopoietic stem cell transplant (hsct)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1030334
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.